• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性电惊厥休克和地昔帕明降低了5-羟色胺和卡巴胆碱对大鼠海马膜中福斯高林刺激的腺苷酸环化酶的抑制程度。

Chronic electroconvulsive shock and desimipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes.

作者信息

Newman M E, Lerer B

机构信息

Department of Research, Jerusalem Mental Health Center, Israel.

出版信息

Eur J Pharmacol. 1988 Mar 29;148(2):257-60. doi: 10.1016/0014-2999(88)90571-7.

DOI:10.1016/0014-2999(88)90571-7
PMID:3378574
Abstract

The degree of inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT and by carbachol in hippocampal membranes was significantly reduced after administration of either chronic ECS (10 days) or desimipramine (10 mg/kg i.p. for 3 weeks). A single ECS had no effect on the 5-HT response and slightly augmented the carbachol response. These results parallel previous observations on the effects of ECS and antidepressants on behavioral responses to 5-HT1a agonists and on muscarinic receptor number, and indicate the possible involvement of these receptors in the mechanism of action of antidepressant drugs.

摘要

在给予慢性电休克(10天)或地昔帕明(10mg/kg腹腔注射,持续3周)后,5-羟色胺(5-HT)和卡巴胆碱对海马膜中福斯高林刺激的腺苷酸环化酶活性的抑制程度显著降低。单次电休克对5-HT反应没有影响,却略微增强了卡巴胆碱反应。这些结果与先前关于电休克和抗抑郁药对5-HT1a激动剂行为反应及毒蕈碱受体数量影响的观察结果相似,表明这些受体可能参与了抗抑郁药物的作用机制。

相似文献

1
Chronic electroconvulsive shock and desimipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes.慢性电惊厥休克和地昔帕明降低了5-羟色胺和卡巴胆碱对大鼠海马膜中福斯高林刺激的腺苷酸环化酶的抑制程度。
Eur J Pharmacol. 1988 Mar 29;148(2):257-60. doi: 10.1016/0014-2999(88)90571-7.
2
Effects of lithium and desimipramine on second messenger responses in rat hippocampus: relation to G protein effects.锂和地昔帕明对大鼠海马体第二信使反应的影响:与G蛋白效应的关系。
Neuropharmacology. 1991 Dec;30(12A):1297-301. doi: 10.1016/0028-3908(91)90026-8.
3
Post-receptor-mediated increases in adenylate cyclase activity after chronic antidepressant treatment: relationship to receptor desensitization.慢性抗抑郁药治疗后受体介导的腺苷酸环化酶活性增加:与受体脱敏的关系。
Eur J Pharmacol. 1989 Mar 21;162(2):345-52. doi: 10.1016/0014-2999(89)90298-7.
4
No alterations in the 5-HT1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity in the hippocampal membranes from rats chronically treated with lithium or antidepressants.长期用锂盐或抗抑郁药治疗的大鼠海马膜中,5-羟色胺1A介导的对福斯高林刺激的腺苷酸环化酶活性的抑制作用无改变。
J Neural Transm Gen Sect. 1991;86(2):85-96. doi: 10.1007/BF01250570.
5
Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.不同的5-羟色胺受体对腺苷酸环化酶的刺激和抑制作用
Biochem Pharmacol. 1990 Oct 1;40(7):1551-8. doi: 10.1016/0006-2952(90)90453-r.
6
Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.死后延迟对大鼠和人脑组织中血清素及(+)8-羟基二丙胺介导的腺苷酸环化酶活性抑制的影响。
Brain Res. 1999 Jan 16;816(1):165-74. doi: 10.1016/s0006-8993(98)01156-1.
7
Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.豚鼠和大鼠海马膜中5-羟色胺1a受体介导的对福斯高林刺激的腺苷酸环化酶活性的抑制作用的表征。
J Pharmacol Exp Ther. 1986 Jul;238(1):248-53.
8
Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.5-羟色胺受体激动剂对福斯高林刺激的腺苷酸环化酶活性的抑制作用。
Eur J Pharmacol. 1985 Dec 17;119(3):231-4. doi: 10.1016/0014-2999(85)90300-0.
9
Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus.氯苯丙胺不能阻止慢性抗抑郁药对大鼠海马中5-羟色胺抑制福斯高林刺激的腺苷酸环化酶的作用。
Eur J Pharmacol. 1991 Jul 12;207(3):209-13. doi: 10.1016/0922-4106(91)90032-d.
10
5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.5-羟色胺1B受体在大鼠黑质中与腺苷酸环化酶呈负偶联。
Eur J Pharmacol. 1988 Jul 7;151(2):189-96. doi: 10.1016/0014-2999(88)90799-6.

引用本文的文献

1
Chronic lithium treatment enhances the postsynaptic 5-HT1A receptor-mediated 5-HT behavioral syndrome induced by 8-OH-DPAT in rats via catecholaminergic systems.长期锂盐治疗通过儿茶酚胺能系统增强8-羟基二丙胺基四氢萘(8-OH-DPAT)诱导的大鼠突触后5-羟色胺1A(5-HT1A)受体介导的5-羟色胺行为综合征。
Psychopharmacology (Berl). 1993;112(1):74-9. doi: 10.1007/BF02247365.
2
Enhancement of cyclic AMP accumulation mediated by 5-HT after chronic amitriptyline treatment in NG 108-15 cells.慢性阿米替林治疗后NG 108-15细胞中5-羟色胺介导的环磷酸腺苷积累增强。
Br J Pharmacol. 1995 Mar;114(6):1282-8. doi: 10.1111/j.1476-5381.1995.tb13344.x.
3
Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.
长期服用抗抑郁药和抗精神病药对中枢神经系统受体的影响。
Cell Mol Neurobiol. 1989 Mar;9(1):1-44. doi: 10.1007/BF00711441.
4
No alterations in the 5-HT1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity in the hippocampal membranes from rats chronically treated with lithium or antidepressants.长期用锂盐或抗抑郁药治疗的大鼠海马膜中,5-羟色胺1A介导的对福斯高林刺激的腺苷酸环化酶活性的抑制作用无改变。
J Neural Transm Gen Sect. 1991;86(2):85-96. doi: 10.1007/BF01250570.
5
Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder.长期使用氟西汀治疗可降低强迫症患者5-羟色胺1A受体反应性。
Psychopharmacology (Berl). 1991;105(3):415-20. doi: 10.1007/BF02244438.
6
The 5-HT receptor--G-protein--effector system complex in depression. I. Effect of glucocorticoids.抑郁症中的5-羟色胺受体-G蛋白-效应器系统复合物。I. 糖皮质激素的作用
J Neural Transm Gen Sect. 1991;84(1-2):3-18. doi: 10.1007/BF01249105.
7
Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function.抑郁症患者及经氯米帕明和锂盐治疗后的血小板腺苷酸环化酶活性:与血清素能功能的关系。
Psychopharmacology (Berl). 1992;109(1-2):231-4. doi: 10.1007/BF02245505.
8
5-HT1A receptor-effector system responsivity in panic disorder.惊恐障碍中5-羟色胺1A受体-效应器系统反应性
Psychopharmacology (Berl). 1992;106(1):111-7. doi: 10.1007/BF02253597.